iPDM-GO

Dr
Allan Jones
Scientific Advisor
Roche Diagnostics GmbH
Dr.
Dagmar Kownatka
Head of Department
Roche Diagnostics GmbH

Integrated Personalised Diabetes Management Goes Europe

iPDM-GO works to improve diabetes care with a programme that rolls out integrated Personalised Diabetes Management in Denmark, enhances that approach with innovative tools and promotes outcomes-based healthcare payment. The goal is to encourage individualised treatment of diabetes, as well as payment systems that reward better healthcare, throughout Europe.

Origins

While the costs associated with chronic diseases continue to rise, many people with diabetes still do not achieve their treatment goals. Personalising diabetes care, by identifying and tailoring services to the unique needs, preferences and circumstances of each individual with diabetes, has been shown to improve the impact of treatment in the PDM-ProValue study programme by Roche Diabetes Care Germany.

Team

iPDM-GO involves a consortium of diverse partners from industry, academia and healthcare administration in Germany, Denmark and the InnoStars regions. Collectively, the team has extensive expertise and skills in clinical practice, computer science, health psychology, health economics, bioinformatics and close-to-market clinical research and development.

The project

The iPDM-GO consortium will implement integrated Personalised Diabetes Management (iPDM), along with an outcomes-based payment model, in a Danish community setting. The goal is to lay groundwork for expanding these concepts to additional European countries. This geographical scaling out to other countries will be guided by a multi-stakeholder advisory board and include a thorough health systems analysis that considers, among other things, market size, ease of access and feasibility.

In parallel, the iPDM-GO consortium will enhance diabetes care by adding a novel patient-assessment tool that captures the unique needs, circumstances and challenges of each person with diabetes, in order to identify the most appropriate solutions and services. Additionally, iPDM-GO will explore new opportunities for leveraging Big Data resources and developing effective educational programmes for health care professionals.

To support the transformation of healthcare from volume-based to value-based, iPDM-GO will develop a healthcare transformation toolkit that guides the implementation of outcomes-based care in European countries.

Impact

iPDM-GO is seeking to make a positive impact on:

  • People with diabetes, by delivering personalised solutions and services that improve their ability to manage their disease, and enhance their quality of life.
  • People with chronic diseases, by promoting results-oriented healthcare.
  • Healthcare systems and payers, by prioritising good results from healthcare services.

Why this is an EIT Health project

iPDM-GO is in keeping with the EIT Health Focus Area of “Care Pathways”, because it seeks to improve care, by making it more results-oriented. The project also aligns with the Focus Area of “Bringing Care Home”, because it encourages an approach that allows people with diabetes to do more to take care of themselves.

External Partners

  • Region Sjælland
  • City of Copenhagen (Københavns Kommune)

EIT Health Partners in this Project